Table 4 Incidence of pregnancy complications
Control group | Preeclampsia group | X² | p | |
|---|---|---|---|---|
Gestational diabetes(GDM) | 33(20.8%) | 21(26.6%) | 1.022 | 0.312 |
Intrahepatic cholestasis of pregnancy(ICP) | 4(2.5%) | 3(3.8%) | 0.304 | 0.582 |
IgA nephropathy | 0(0%) | 1(1.3%) | 2.021 | 0.155 |
In vitro fertilization embryo transfer(IVF-ET) | 19(11.9%) | 20(25.3%) | 6.882 | 0.009 |
History of preeclampsia | 1(0.6%) | 10(12.7%) | 17.325 | <0.001 |
Ureaplasma urealyticum infection | 8(5%) | 10(12.7%) | 4.391 | 0.036 |
Scarred uterus | 25(15.1%) | 4(5.1%) | 5.116 | 0.024 |
Macrosomia | 2(1.3%) | 0(0%) | 1.002 | 0.317 |
Lack of umbilical blood flow | 0(0%) | 2(2.5%) | 4.059 | 0.044 |
Placental abruption | 0(0%) | 5(6.3%) | 10.279 | 0.001 |
Complete placenta previa | 2(1.3%) | 0(0%) | 1.002 | 0.317 |
Uterine myoma | 8(5%) | 10(12.7%) | 4.391 | 0.036 |
Fetal distress | 2(1.3%) | 2(2.5%) | 0.518 | 0.472 |
Hypothyroidism | 4(2.5%) | 3(3.8%) | 0.304 | 0.582 |
Hyperthyroidism | 1(0.6%) | 1(1.3%) | 0.257 | 0.612 |
Obesity | 2(1.3%) | 7(8.9%) | 8.385 | 0.004 |
Polycystic ovary syndrome(PCOS) | 0(0%) | 1(1.3%) | 2.021 | 0.155 |
Systemic lupus erythematosus(SLE) | 2(1.3%) | 0(0%) | 1.002 | 0.317 |
Thalassemia | 6(3.8%) | 5(6.3%) | 0.782 | 0.377 |
Premature rupture of membranes | 0(0%) | 1(1.3%) | 2.021 | 0.155 |
Oligohydramnios | 2(1.3%) | 0(0%) | 1.002 | 0.317 |
Twin pregnancies | 1(0.6%) | 3(3.8%) | 3.207 | 0.073 |